Rationales for the Use of Cancer Stem Cells Markers in the Staging of Papillary Thyroid Carcinoma

Figure 2

Representative image of immunohistochemistry staining of CD44 in benign and papillary thyroid carcinoma tumor tissues (400X). (a) Benign tumor section. (b) Stage 1 papillary thyroid cancer tissue. (c) Stage II papillary thyroid carcinoma. (d) Stage III papillary thyroid carcinoma.

(a)

(b)

(c)

(d)